Holland, OH, United States of America

Ervin Faulmann


Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ervin Faulmann

Introduction

Ervin Faulmann, an inventor based in Holland, OH, has made significant strides in the field of immunology through his innovative work. With a total of four patents to his name, he has actively contributed to advancing medical science, particularly in the development of immunoglobulin-binding proteins.

Latest Patents

Faulmann's recent innovations include two pivotal patents focusing on the isolation of IgA immunoglobulins. The first patent, titled "Materials and Methods for Isolating IgA Immunoglobulins," discusses novel polynucleotide sequences that encode polypeptides specifically designed to bind IgA. A key aspect of this patent involves creating hybrid proteins that incorporate binding domains for both IgA and IgG, enhancing the versatility of immunological applications. His second patent, "Gene and Method for Production of an IgA Binding Protein," also revolves around similar polynucleotide sequences and further explores methods for detecting IgA in various biological samples. Both inventions reflect Faulmann’s commitment to improving diagnostic and therapeutic techniques in immunology.

Career Highlights

Faulmann has established himself as a prominent figure in the field of medical research, currently operating at the Medical College of Ohio. His work has laid the groundwork for future innovations that can potentially reshape understanding and treatment of immunological conditions. With his emphasis on practical applications of his research, he aims to bridge the gap between laboratory findings and clinical practice.

Collaborations

Throughout his career, Faulmann has likely engaged in various collaborative efforts with fellow researchers and institutions to further enhance his inventions and their applications. Although specific collaborations are not detailed, partnerships in academia often lead to shared resources and insights that drive innovation.

Conclusion

Ervin Faulmann continues to demonstrate the essence of innovation through his patents and contributions to the medical field. His focus on developing methods and materials for isolating immunoglobulins showcases the potential for significant advancements in diagnostics and therapeutics. With a solid foundation in research and a commitment to improving healthcare, Faulmann represents the best of what modern inventors can achieve in their pursuit of knowledge and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…